Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Biotechnology & Genetic Engineering Reviews|February 27, 2014
Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agentsMaria Laura Belladonna, Ursula GrohmannFrontiers in Pharmacology|July 9, 2020
Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19Maria Laura Belladonna, Ciriana OrabonaCells|November 27, 2024
The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)Chiara Suvieri, Maria Laura Belladonna, Claudia VolpiInternational Journal of Pharmaceutics|January 1, 2026
Gallium-integrated HA/CaCO3 scaffold and its effect on gram-positive bacteria and osteoclastogenesisMichela Piccinini, Chiara Suvieri, Maria Laura Belladonna, et al.Journal of Virology|August 17, 2004
Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic miceMasanori Matsui, Osamu Moriya, Maria Laura Belladonna, et al.Cytokine|May 25, 2015
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetesGiada Mondanelli, Claudia Volpi, Roberta Bianchi, et al.Cancer Research|June 17, 2006
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanomaShuntaro Oniki, Hiroshi Nagai, Tatsuya Horikawa, et al.Pharmaceutics|June 24, 2022
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell ModelCiriana Orabona, Elena Orecchini, Claudia Volpi, et al.BJU International|March 26, 2011
IL-23 gene therapy for mouse bladder tumour cell linesTomomi Kuramoto, Reona Fujii, Hiroshi Nagai, et al.Cancer Research|February 12, 2004
Potent antitumor activity of interleukin-27Masayuki Hisada, Sadahiro Kamiya, Koji Fujita, et al.Pageof 5